Scientists develop promising antibodies to prevent Epstein-Barr infection
Dr. Andy McGuire characterized his team’s work to develop antibodies against Epstein-Barr virus as “a significant stride for the scientific community and the people at the highest risk of complications from this virus.”
HIV’s most promising breakthrough has taken a hit
Dr. Jim Kublin explained that approaches using the mRNA platform for developing an HIV vaccine “are not at all dead in the water” despite mild side effects observed in a recent study.
HIV’s most promising breakthrough has taken a hit
Dr. Jim Kublin explained that approaches using the mRNA platform for developing an HIV vaccine “are not at all dead in the water” despite mild side effects observed in a recent study.
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”
After decades of failures, researchers have renewed hopes for an effective HIV vaccine
Dr. Julie McElrath declared in a plenary talk at CROI that “An HIV vaccine could end HIV. So I say, ‘Let’s just get on with it.’”
Local researchers progressing on malaria vaccine
Segment features interviews with malaria researcher Dr. Jim Kublin and study participants Molly Perry and Joelle Mumley who took part in a study coordinated by Kublin at the Fred Hutch-based Seattle Malaria Clinical Trials Center
Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease
A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine
New vaccine candidate could be the next step toward eliminating malaria
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine
Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Volunteers get bit to test new strategy for malaria vaccine
Story covers a study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research that found genetically engineered malaria parasites could be a promising approach to developing a malaria vaccineh
A genetically modified malaria vaccine has passed an important hurdle
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
An inside look at the labs where doctors intentionally infect people with malaria
Article about the quest to develop a malaria vaccine mentions Dr. Jim Kublin, medical director of the Malaria Clinical Trials Center and an investigator at Fred Hutch
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
Charlie Sheen's HIV not likely a death sentence
Quotes Dr. Julie McElrath, director of Fred Hutch's Vaccine and Infectious Disease Division